Clinical Evaluation of the Effects of Mirror Therapy in Patients With Complex Regional Pain Syndrome (CRPS) Type 1

Sponsor
Ankara University (Other)
Overall Status
Completed
CT.gov ID
NCT03377504
Collaborator
(none)
36
1
2
35
1

Study Details

Study Description

Brief Summary

CRPS Type 1 can occur after traumas, surgical applications or central nervous system disorders. The triggering factor in CRPS type 1 is fracture in about half of the cases. Mirror therapy is an innovative treatment approach that is cheap, easy to administer and non-invasive. It is thought that this treatment may be complementary to other rehabilitation methods.Neurophysiologic effects of mirror therapy are noted in the brain, especially in the parietal region, cerebellum, basal ganglia and premotor cortex. Mirror therapy is also effective through the mirror neuron system. Mirror therapy triggers neuroplasticity by increasing the connection between neurons in the brain and thereby enhances communication between the motor and the sensory cortex. Recent studies have shown the positive effects of mirror therapy in patients with CRPS Type 1 disease. There are two randomized controlled trials showing the efficacy of mirror therapy in patients with CRPS Type 1 after stroke. Only one pilot study was performed in patients with CRPS Type 1 who were traumatic origin. There are no randomized controlled trials investigating the efficacy of mirror therapy in CRPS Type 1 patients who developed secondary to trauma in the literature. The purpose of this study is to investigate the clinical effects of mirror therapy applied in addition to routine rehabilitation program in patients with traumatic CRPS Type 1. The investigators hypothesized that adjunctive mirror therapy to classical rehabilitation program would result in better outcomes compared with the classical program only.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: mirror therapy
  • Behavioral: Routine physical therapy and exercise program
N/A

Detailed Description

This study is planned as a prospective randomized single blind controlled study. It was approved by the Ankara University Faculty of Medicine Ethics Committee and was conducted in accordance with the Declaration of Helsinki. This study will include 36 patients with CRPS type 1 who are referred to the Depart-ment of Physical Medicine and Rehabilitation, Hand Rehabilitation Unit at the Medical Faculty of Ankara University. Patients included in the scope of the study will randomly be divided into 2 groups as mirror group and control group. Random allocation software (RAS) program will be used to assign the patients to the treatment groups with "block randomization" method and to create the randomization scheme. In this single blinded study, all patients will be evaluated by the same physician (Dr. Elif Can Ozdemir). The physician will be blind to patient's assignment. Routine physical therapy and exercise program including contrast baths, hot pack, transcutaneous electrical nerve stimulation (TENS), desensitization, exercises and occupational therapy will be applied to all patients for a total of 4 weeks, 5 days a week, 1 hour/day. Mirror therapy will be applied to the mirror group for 30 minutes per day in addition to this routine treatment. Mirror therapy will include wrist flexion/extension, ulnar/radial deviation, hand finger flexion/extension and ab-duction/adduction, thumb abduction/adduction/opposition, and forearm supina-tion/pronation movements as well as various object grasping activities according to the status of the patient's hand functions. A total of 20 sessions of treatment will be given to each patient. The therapy will be given by the physiotherapists in the Hand Rehabilitation Unit. All individuals participating in the study will be assessed before and immediately after the treatment and also 1 month at follow-up. Each assessment will include pain severity, grip strength, lateral pinch strength, hand circumference measurements, hand dexterity, hand function in daily living activities, and health-related quality of life.As the primary outcome variable, the difference in pain measured by the Numerical Rating Scale between baseline and post-treatment is based. In the mirror group, at least 1 point difference in pain according to the control group is evaluated by Mann Whitney U test and it is necessary to take a total of 36 patients with 81% power and 5% error in each group, assuming 1 as the group standard deviation. Mann Whitney U and Wilcoxon test are planned for paired samples. P value of less than .05 is considered as statistically significant.

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective randomized single blind controlled studyProspective randomized single blind controlled study
Masking:
Single (Outcomes Assessor)
Masking Description:
single blind (outcomes assessor)
Primary Purpose:
Treatment
Official Title:
Clinical Evaluation of the Effects of Mirror Therapy in Patients With Complex Regional Pain Syndrome (CRPS) Type 1:Prospective Randomized Single Blind Controlled Study
Actual Study Start Date :
Mar 1, 2017
Actual Primary Completion Date :
Dec 1, 2019
Actual Study Completion Date :
Jan 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: mirror group

Routine physical therapy and exercise program will be applied to all patients for a total of 4 weeks, 5 days a week, 1 hour/day. Mirror therapy will be applied to the mirror group for 30 minutes per day in addition to this routine treatment.

Behavioral: mirror therapy
Mirror therapy will include wrist flexion/extension, ulnar/radial deviation, hand finger flexion/extension and abduction/adduction, thumb abduction/adduction/opposition, and forearm supination/pronation movements as well as various object grasping activities according to the status of the patient's hand functions.

Active Comparator: control group

Routine physical therapy and exercise program will be applied to all patients for a total of 4 weeks, 5 days a week, 1 hour/day. A total of 20 sessions of treatment will be given to each patient.

Behavioral: Routine physical therapy and exercise program
Routine physical therapy and exercise program including contrast baths, hot pack, TENS, desensitization, exercises and occupational therapy will be applied to all patients

Outcome Measures

Primary Outcome Measures

  1. Pain severity [change from baseline at 4 weeks and 8 weeks]

    "0-10 Numeric Rating Scale (NRS)" will be used to assess current pain severity. 0 points minimum 10 points indicates the maximum value. Low scores are associated with better clinical outcomes.

Secondary Outcome Measures

  1. Grip strength [change from baseline at 4 weeks and 8 weeks]

    The Jamar dynamometer will be used to measure the grip strength. The best result of the 3 sequential measurements will be taken into account

  2. Lateral pinch strength [change from baseline at 4 weeks and 8 weeks]

    A pinchmeter will be used to measure the lateral pinch strength. The best result of the 3 sequential measurements will be taken into account.

  3. Hand circumference measurements [change from baseline at 4 weeks and 8 weeks]

    Two measurements will be made: one at the level of ulnar styloid process, second at the level of the third distal metacarpal tip

  4. Hand dexterity [change from baseline at 4 weeks and 8 weeks]

    Moberg pick up test will be used.

  5. Hand function in daily living activities [change from baseline at 4 weeks and 8 weeks]

    Cochin Hand Function Scale (CHFS) will be used.0 points minimum 90 points shows the maximum value. Low scores are associated with better clinical outcomes.

  6. Health-related quality of life [change from baseline at 4 weeks and 8 weeks]

    The Nottingham Health Profile (NHP) will be used

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult individuals over 18 years of age

  • CRPS type 1 diagnosis according to 2003 Budapest diagnostic criteria

  • Patients who developed CRPS Type 1 due to traumatic causes (surgical procedures, fractures, immobilization)

  • Patients who agree to participate in the study and sign the informed consent form

Exclusion Criteria:
  • Patients with peripheral nerve injuries (those with a diagnosis of CRPS type 2 according to Budapest criteria)

  • Patients with CRPS Type 1 after central nervous system injury (stroke)

  • Patients in the acute and post-acute rehabilitation who have had primary or secondary tendon repair of the hand

  • The presence of comorbid conditions (e.g. decompensated heart failure, chronic renal insufficiency, malignancy) that would impair the functioning of the person and the health-related quality of life

  • The presence of comorbid disease affecting hand function (e.g. rheumatoid arthritis, psoriatic arthritis or other inflammatory diseases that cause hand involvement)

  • Patients with acute deep venous thrombosis and arterial thrombosis of the upper extremity

  • Patients with arterial / venous injury and / or undergoing arterial revascularization

  • Patients with excessive alcohol and inappropriate opioid use

  • Patients with untreated psychiatric problems (major depression, anxiety, schizophrenia, etc.)

  • Patients with recurrent CRPS Type 1

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ankara University Faculty of Medicine, İbn-i Sina Research and Application Hospital Ankara Turkey 06030

Sponsors and Collaborators

  • Ankara University

Investigators

  • Principal Investigator: Ayşe Adile Küçükdeveci, Ankara University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ayşe A Küçükdeveci, MD, Professor of Physical Medicine and Rehabilitation, Ankara University
ClinicalTrials.gov Identifier:
NCT03377504
Other Study ID Numbers:
  • 03-109-17
First Posted:
Dec 19, 2017
Last Update Posted:
Feb 25, 2020
Last Verified:
Feb 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ayşe A Küçükdeveci, MD, Professor of Physical Medicine and Rehabilitation, Ankara University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 25, 2020